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ABSTRACT The biological basis for the observed modulation in cytoplasmic progesterone
receptors (PgR) of normal mammary gland occurring during mammary development was
investigated. Specifically, the relative roles of hormones vs. differentiation on (a) the decrease
in PgR concentration during pregnancy and lactation and (b) the loss of mammary responsive-
ness to estrogen during lactation were examined. PgR were measured using the synthetic
progestin, R5020, as the ligand. The hormones estrogen and progesterone were tested in vivo
for their effect on PgR concentration. Mammary gland differentiation was assessed morpho-
logically and by measuring enzymatically active a-lactalbumin.
These studies show that there is a stepwise decrease in PgR that occurs in two stages. The
first decrease is completed by day 12 of pregnancy and the second decrease occurs only after
parturition. There appears to be a hormonal basis for the first decrease and it appears to be
caused by the negative effect of progesterone on estrogen-mediated increase in PgR. In direct
contrast, the absence of PgR during lactation and the mammary tissue insensitivity to estrogenic
stimulation of PgR were not related to the hormonal milieu of lactation but were directly
related to the secretory state of the mammary gland and lactation per se.
In rodents the two ovarian hormones, estrogen and progester-
one, are both critically required formammarycell proliferation
and lobuloalveolar differentiation (LAD) during pregnancy.
Estrogen stimulates cell proliferation (2, 23, 29), whereas pro-
gesterone in concert with estrogen causes morphogenesis of
mammary alveoli (2, 11, 23, 29). Progesterone also prevents the
initiation of lactation before parturition (8-10, 19, 39). Also,
once lactation is established, it can proceed normally in the
absence of ovaries (7).
For steroid hormones to produce a biological response, it is
believed that they must initially interact with their macromo-
lecular cytoplasmic receptors (l7). In target tissues forestrogen
and progesterone such as the uterus and certain normal and
neoplastic mammary tissues, cytoplasmic estrogen receptors
(ER) and progesterone receptors (PgR) are present. Further-
more, PgR synthesis in these tissues appears to be under
estrogenic control and thus PgR can also serve importantly as
markers of estrogen action (13-15, 20, 26, 28, 37, 38, 41, 43).
We have previously reported that PgR concentration per cell
varies with the developmental state of the mammary gland;
PgR are present in virgin gland, decrease during pregnancy,
are undetectable during lactation, and reappear during lacta-
tional involution (14). Most striking is the observation that not
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only are PgR absent during lactation but also that estrogen
administration to lactators fails to result in the increased con-
centration of mammary PgR. This inability to respond to
estrogen is specific to lactating mammary tissue because (a)
uteri of lactating mice respond to exogenous estrogen with
increased PgR levels and (b) in virgin mammary gland the
level of PgR is augmented by estrogen administration in a
manner similar to that for the uterus (13). The present studies
were undertaken to determine the basis for (a) the observed
modulation in PgR concentration during mammary develop-
ment and (b) the loss of mammary responsiveness to estrogen
during lactation.We found that therewas a hormonal basis for
the decrease in PgR concentration that occurs during preg-
nancy and that this decrease was most likely attributable to
progesterone. In contrast, the absence of PgR during lactation
was not related to the hormonal milieu of lactation but was
directly related to thesecretory state of the gland and lactation
per se.'
' A preliminary report of this work hasbeen published: Haslam, S. Z.,
and G. Shyamala. 1979. Modulation of progesterone receptors in
normal mammary tissue. J. Cell Biol. 83(2, Pt. 2):238a (Abstr.).
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Animals
Female BALB/c mice were used at 2-5 mo of age and were from our own
colony, Intact or ovariectomized virgin, pregnant, or lactatingmice were obtained
and used as described previously; ovariectomized virgin mice were used 14 dafter
ovariectomy (13, 14). In certain experiments, animals were ovariectomized and
hysterectomized on day 14-16 of pregnancy, and hormone injections were
initiated 24 hlater. Unilateral thelectomy (nipple removal) was accomplished by
cauterization before mating; litter sizes were adjusted to six pups.
Isotope
The synthetic progestin [''H]R5020 (17,21-dimethyl-19-nor-4,9-pregnadiene-
3,20-dione) (sp act, 86.0 Ci/mmol) was purchased from New England Nuclear,
Boston, Mass.
Hormones
All hormones used for injections were purchased from Sigma Chemical Co.,
St. Louis, Mo. Unlabeled R5020 was purchased from NewEnglandNuclear. The
hormones were administered by subcutaneous injection as a solution in 1%
ethanol in saline or in sesame oil.
Steroid Receptor Assay
Tissue homogenates were prepared in a phosphate-glycerol buffer (5 mM
sodium phosphate, 10 mM thioglycerol, 10% glycerol, pH 7.4) and centrifuged at
12.350 g for 1 h. Mammary glands were homogenized at a concentration of I
gm/ml. Unless otherwise specified, the superriates designated as cytoplasmic
extracts were used for steroid receptor assays. For measurements ofPgR, aliquots
ofcytoplasmic extracts were incubated with 20 nM of f`H]R5020 alone or in the
presence of a 100-fold excess ofunlabeled 85020. All cytoplasmic extracts were
incubated with hormones at 4°C for 4 h before assay. The bound readioactive
steroid in all the incubations was estimated using the dextran-coated charcoal
assay ofKorenman (18) as described previously (42) for mammary glands.
Some further comments on the estimation of PgRconcentration in the present
studies using R5020 as the ligand are necessary. Previously, we have reported
that dexamethasone can significantly compete for certain specific 85020-binding
sites; however, these binding sites did not appear to be high-affinity PgR (42).
Subsequent studies have revealed that inclusion of dithiothreitol (DTT) in the
buffer augments the degree ofcompetition by dexamethasone to specific R5020-
binding sites, and this is compatible with recent observations in our laboratory
that the glucocorticoid-binding sites in mammary tissues are stabilized by DTT
(24). Therefore, in the present studies, DTTwas not included in the homogenizing
buffer; however, it should be mentioned that even when DTT was excluded,
some dexamethasone competition was still observed. In all cases, even if the
binding data are corrected for dexamethasone competition, the relative results
remain unchanged. For these reasons and because the precise identity of these
dexamethasone-competible sites is as yet unclear, the specific binding data
reported in these studies do not include any correction for competition by
dexamethasone to specific 85020-binding sites. We have also determined that
endogenously bound progesterone would be exchanged 100% by 85020 under
the present assay conditions' in a manner similar to that reported for mouse
uterus (36); thus, values for specific 85020 binding represent the total number of
cytoplasmic PgR.
a-Lactalbumin Measurement
a-Lactalbumin activity was assayed by the method of Ip and Dao(16), based
on that ofEbner et al. (10), with modifications as follows. Mammary tissue was
homogenized with one 15-s burst of a Polytron PT 10-ST (Brinkmann Instru-
ments, Inc., Westbury, N. Y.). Homogenates were not centrifuged but used after
filtration through organza. The reaction mixture contained either 20 or 50 JAI of
homogenate, 2 paint Tris-HCI buffer (pH 7.4), 1 pmol MnClt, 60 nmol UDP-
galactose (supplemented with --15,000 cpm UDP-["C]galactose [New England
Nuclear]). The total volume of the reaction mixture was 100 pl. a-Lactalbumin
activity was estimated in the presence ofexcess bovine milkgalactosyl-transferree
(5 mU; Sigma Chemical Co.) and 2 iumol of r)-glucose acceptor to form
("C]lactose. Astandard curve was generated with increasing amounts of bovine
a-lactalbumin to ensure that the reaction was in the linear portion of the curve
with respect to a-lactalbumin concentration. To correct for the nonspecific
production of ["C]galactose resulting from endogenous hydrolysis of UDP-
z S. Z. Haslam andG. Shyamala, unpublished observations.
['"C]galactose, a control reaction was included for each sample, using distilled
water in place ofglucose astheacceptor. Theincubations ofthereaction mixture
were carried out at 37°C for 30 minin a shaking water bath; the reaction was
stopped bycooling in ice and the addition of I00,ul of cold water. The contentof
each tube was passed through a column (0.5 x 4 cm) ofBio-Rad AG 1-X2 anion
exchange resin (Bin-Rad Laboratories, Richmond, Calif .) in the chloride cycle.
Reaction tubeswere washed with 0.5 ml ofwater that was then transferred to the
columns. Neutral sugars on the column were eluted with another I ml ofwater
directly into scintillation vials. Radioactivity in the eluate was measured with 10
ml of formula 950A (New England Nuclear) by liquid scintillation counting.
Recovery of neutral sugars from the column was >80% with no elution of UDP-
galactose. The product of the enzymatic reaction was identified as lactose by
paper chromatography (34).
To assess mammarygland morphology and extent of LAD, mammary tissue
samples were prepared for histological examination as described previously (14).
The extent of LAD was evaluated by estimating the percentage of mammary
tissue that was represented by epithelial cells in lobuloalveolar organization.
Sections of mammarytissue in which --50% of the epithelial cells were lobuloal-
veolar were scored as ++, whereas sections in which close to 100% of the
epithelial cells were lobuloalveolar were assigned a score of ++++. An average
of 10 pieces of tissue were examined microscopically for each experimental
condition that was evaluated for LAD.
DNA content of the tissues was estimated according to Ceriotti (3), and
protein concentration was assayed according to Lowry et al. (22).
RESULTS
The Pattern of PgR Modulation in Relation to
Mammary Gland Differentiation in Intact Mice
Ourearlier studies indicated that mammary PgR concentra-
tion was modulated as a function of mammary gland devel-
opment. Namely, we found that PgR were abundant in virgin
gland, were decreased during pregnancy, and were totally
undetectable during lactation (14). To identify the physiologi-
cal basis for these observed modulations in mammary PgR, in
the following studies we examined the relationship between
mammary PgR and mammary differentiation. There are a
number of morphological and biochemical criteria that can be
used to measure the progression of mammary gland differen-
tiation from the undifferentiated ductal epithelium of virgin
mice to the fully differentiated secretory lobuloalveolar epithe-
lium oflactatingmice. In thepresentstudies onemorphological
criterion and one biochemical criterion were used, namely
degree of lobuloalveolar differentiation (LAD) and amount of
a-lactalbumin activity. In mice, LAD occurs mainly during
TABLE I
Relationship between Mammary PgR Concentration and
Mammary Gland Differentiation
Lactating, d
￿
Lobuloalveolar/
secretory:
2
￿
0
￿
189 ± 7
￿
++++
11-15
￿
0
￿
277 t 50
￿
++++
' For method of estimating degree of LAD, see Materials and Methods. All
values represent mean t SEMof two to four experiments.
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Develop- Specific Mammary
mental [3HIR5020 a-Lactalbumin gland morphol-
state binding activity ogy
fmollmg DNA pmot lactose degree of LAD'
formed/ mg
tissuel30 min
Virgin 1,610 t 193 Not detectable Ductal: none
Pregnant, d
12 350 t 32 -
Lobuloalveolar:
+
14 349 t 63 5 t 1 ++
16 315 t 26 13 t 1 +++
19 342 t 88 82 t 37 ++++pregnancy, whereas a-lactalbumin activity, which is barely
detectable during pregnancy, increases dramatically around
parturition and reaches peak levels during lactation (25) .
The results of the studies on the relationship between mam-
marygland differentiation andPgR levels during normalmam-
mary gland development in intact untreated mice as summa-
rized in Table I reveal two stages ofPgR modulation. The first
80% reduction in mammary PgR is completed by day 12 of
pregnancy and the second reduction, resulting in a total loss of
PgR, occurs after parturition . It is of interest that after day 12
of pregnancy, although there is no further decrease in mam-
mary PgR, the gland continues to become progressively more
differentiated as indicated by the increases in a-lactalbumin
activity and LAD (Fig . I a_f). Thus these data suggested that
there is not a causal relationship between mammary PgR and
differentiation . This raised the possibility that the factors re-
sponsible for the decrease in PgR were also simultaneously
leading to mammary differentiation .
The Effects of Estrogen and Progesterone on
Mammary PgR and Differentiation
The two major hormones of pregnancy, estrogen (E) and
progesterone (P), are known to influence that PgR level in
various target tissues (20, 25, 38, 43) and are also known to
cause epithelial cell proliferation and LAD in mammary glands
of ovariectomized virgin mice (2, 29) . For these reasons, in the
following experiments the simultaneous effect of E and P on
mammary PgR levels and differentiation was examined. To
distinguish the direct effects of the hormones on PgR levels
FIGURE 1
￿
Mammary gland morphology during pregnancy and lactation . (a) . Day 12 of pregnancy . Adipose cells are predominant ;
epithelial cells starting to form small lobules of alveoli . (b) . Day 14 of pregnancy . An increased number of epithelial cells are
present and the alveolar lobules are larger than in a . (c) Day 16 of pregnancy. The amount of adipose tissue has been reduced and
alveolar lumina are dilated and appear to be filled with fat droplets . (d) Day 19 of pregnancy . There has been a further decrease
in adipose cells . (e and f) Days 2 and 7 of lactation . No adipose cells are visible . Alveolar lumina are extensively dilated and
secretion filled, indicating an actively secretory state of the gland . Hematoxylin and eosin . x 125 .
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gland differentiation, we quantitated PgR after different
lengths of time of hormone treatment and correspondingly
different degrees ofLAD .
The morphology of mammary glands of ovariectomized
virgin mice after estrogen and progesterone treatment is shown
in Fig . 2 a-e . After treatment with oil, E or P alone for 7 or 14
d or E and P for 7 d, mammary glands were predominantly
ductal and thus undifferentiated . In contrast, the mammary
glands of mice treated with E and P for 14 d had begun
differentiation as indicated by the presence of alveoli .
The effect of E and P on mammary PgR concentration in
ovariectomized virgin mice is shown in Fig. 3 . Administration
of E alone for either 7 or 14d resulted in a significant increase
in mammary PgR . Administration of P alone for either 7 or 14
d resulted in PgR levels similar to those of vehicle control,
whereas P in combination withE for 7 d resulted in PgR values
not significantly different from those obtained with E alone .
However, administration of P in combination with E for 14 d
resulted in a 20% decrease ofmammary PgR as compared to
treatment with E alone . Although it was clear that E could
cause an increase in mammary PgR and that P can cause a
decrease in PgR, the 20% reduction in PgR caused by proges-
terone under the above experimental conditions could not
account for the 800 10 reduction in PgR that is observed during
pregnancy . This raised the possibility that during pregnancy
the loss of PgR might have resulted from either a decreased
sensitivity of mammary tissue to estrogen or an increased
ability ofprogesterone to decrease PgR. The following experi-
ments were carried out to distinguish between these two pos-
sibilities.
In these studies, 24 h before the initiation of hormone
treatment, pregnant mice (14-16 d) were ovariectomized and
hysterectomized to remove the major sources of endogenous
hormones, and then the effects of E and P on mammary PgR
were tested. The results of these experiments are presented in
Fig . 4 . Withdrawal of hormones for 24 h (time zero control) or
5 d (vehicle group) resulted in a decrease in PgR, whereas
administration of E alone produced a significant increase in
PgR . In contrast to its effect in mammary glands of ovariec-
tomized virgins, P in combination with E produced a greater
decrease in PgR (600 1o vs. 20%) and the PgR concentration was
similar to that observed in intact pregnant mice. Thus the data
in Fig . 4 clearly indicated that the decrease in mammary PgR
during pregnancy was not the result ofa decrease in estrogenic
sensitivity of the tissue with respect to PgR increase but rather
was the result of an enhanced ability of progesterone to de-
crease PgR . Furthermore, it also demonstrated that the differ-
entiation of mammary gland in itself did not alter the mam-
mary tissue responsiveness to estrogen . Consequently, it was
also clear that factors other than mammary gland differentia-
tion that occurs during pregnancy must have been responsible
for the total loss of PgR and the loss of responsiveness to
estrogen that is observed after parturition . This led us to
consider that lactation and secretion per se might have an
independent effect on PgR concentration and responsiveness
to estrogen .
FIGURE 2
￿
Mammary gland morphology of ovariectomized virgins after administration of estrogen and progesterone . (a) Control
(14 d oil) . (b) Progesterone treatment (14 d) . (c) Estrogen treatment (14 d) . In all three treatment groups, there is a predominance
of adipose cells and sparse ducts composed of epithelial cells . (d) . Estrogen and progesterone treatment (7 d) . The amount of
epithelial cells and number of ducts are increased . (e) Estrogen and progesterone treatment (14 d) . The amount of epithelial cells
is further increased and a small lobule of alveoli is present . Hematoxylin and eosin . x 125.
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FIGURE 3
￿
The effects of estrogen and progesterone on mammary
PgR concentration . Virgin mice ovariectomized 14 d before the
onset of hormone treatment were injected daily for 7 (O) or 14 a
d with either vehicle, progesterone (P, 1 mg), estrogen (E, 1 FLg), or
estrogen plus progesterone (E + P, 1 hg + 1 mg, respectively).
Control (IM mice were assayed 14 d after ovariectomy alone; i.e.,
this represents the concentration of PgR at the initiation of hormone
treatment. Cytoplasmic extracts of mammary glands were assayed
for specific [3H]R5020 binding 24 h after the last injection. Each
value represents the mean t SEM of three to four experiments;
tissues from two animals were pooled for each experiment. Asterisk,
P = .05 14-d E + P < 14-d E (Student's t test) .
and Estrogen Responsiveness of
C VEHICLE P E E+P
FIGURE 4
￿
Effects of estrogen and progesterone on PgR concentra-
tion in mammary gland after 14-16 d of pregnancy. Pregnancies
were terminated by ovariectomy and hysterectomy on day 14-16;
starting 24 h later, the animals received afurther five daily injections
of vehicle, or estrogen (E, 1 lag) or progesterone (P, 1 mg) alone or
in combinations, as indicated. Controls (c) were assayed at 24 h
after ovariectomy and received no other treatment. 24 h after the
last injection, cytoplasmic extracts were assayed for specific [3H]-
R5020 binding. Each value represents the mean t SEM of three to
four experiments.
Relationship of Lactation to PgR Modulation
To identify the precise effect of lactation on PgR, we felt
that it was necessary to dissociate the hormonal milieu of
lactation from the secretory state of the tissue. It is well known
(7) that, in addition to the appropriate hormonal milieu, initi-
ation and maintenance of copious milk secretion requires the
physical removal of milk; this is accomplished in nature by
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suckling. By preventing suckling on one side of a lactating
mouse, using the technique of unilateral thelectomy (nipple
removal), we were able to obtain fully lactating mammary
tissue from nipple-intact glands and nonlactating mammary
tissue from the thelectomized glands from the same postpartum
mouse (40). As can be seen from Table II, thelectomy in itself
had no effect on mammary PgR in virgin and pregnant animals
and it also did not prevent the decrease in PgR observed during
pregnancy. A significant difference between PgR levels of
intact and thelectomized glands was detectable only in post-
partum mice; in this case, PgR were always detectable in the
thelectomized, nonlactating glands but were absent in the
contralateral intact lactating glands. Table II also shows that
although thelectomy had no effect on mammary differentiation
during pregnancy as assessed by a-lactalbumin activity, in
postpartum mice the thelectomized glands had less a-lactal-
bumin activity compared to the intact lactating glands. The
low a-lactalbumin activity of thelectomized glands was attrib-
utable to the non-lactational state of the gland and was corrob-
orated histologically (Fig. 5a-d).
We next examined the effect of estradiol on PgR of mam-
mary glands in unilaterally thelectomized mice. These results
are presented in Table III. We were consistently able to increase
PgR concentration by exogenous administration of E in thelec-
tomized, nonlactating mammary tissue, whereas PgR failed to
be augmented by E in lactating nonthelectomized mammary
tissue; the uteri of these animals also responded to E with
increased level of PgR.
DISCUSSION
The results of our present studies indicate that as mammary
glands of virgin mice differentiate there is a stepwise loss of
PgR that occurs in two stages. The first decrease in PgR is
completed by day 12 ofpregnancy, whereas the second decrease
occurs after parturition and results in a total loss of PgR in
mammary tissue. Estrogen and progesterone appear to be the
principal regulators of PgR concentration in mammary tissue;
estrogen increases PgR concentration, whereas progesterone
reduces the concentration of PgR. In view of these hormonal
effects on PgR concentration, and because estrogen and pro-
TABLE II
Effect of Thelectomy on PgR Concentration and a-
Lactalbumin Activity in Mammary Gland
Develop-
mental state
All values represent the mean ± SEM of two to five experiments.
' Mice were thelectomized before mating or, in case of virgins, 2-4 wk before
tissue was assayed.
Specific [3H]R5020 binding
a-Lactalbumin
activity
Thelec- Thelec- Intact
tomized* Intact tomized mam-
mammary mammary mammary mary
gland gland gland gland
Virgin
fmollmg
1,884 t 308
DNA
1,972 t 234
pmol
formed/
tissuel30
lactose
mg
min
Pregnant, d
14 486 t 33 507 t 86 5 t 1 6t 1
Lactating, d
2 338[33 0 55±5 197 t8
7 182 1 72 0 - -FIGURE 5
￿
Effect of thelectomy on mammary glands of postpartum mice . Thelectomized mammaryglands (a) . 2d postpartum and
(b) 7 d postpartum . Mammary gland morphology is similar to that at 16 d of pregnancy (Fig . 1 c) ; theglands are lobuloalveolar, but
alveoli have small lumina indicative of a nonsecretory condition . Contralateral nipple-intact mammary glands (c) 2 d postpartum
and (d) 7 d postpartum . In contrast to Fig . 5 a and b, alveolar lumina are extensively dilated and secretion filled, thus indicating an
actively secretory condition . Hematoxylin and eosin . x 125.
TABLE III
Estrogen Stimulation of PgR in ThelectomizedMice
Specific (3HIR5020 binding
Treatment* Thelectomized Intact
Uterus
NaCI
￿
5,860 t 1,370
E
￿
11,263 t 1,355
fmof/mg DNA
￿
fmol/mg DNA
Mammary Gland
NaCl
￿
175 t 22
￿
0
E
￿
325 t 34
￿
0
Mice were unilaterally thelectornized before mating and, 11 d postpartum,
were injected subcutaneously with 3 tag of either E or NaCl . Tissues were
assayed for PgR 24 h later . Each value represents the mean t SEM of three
to five experiments .
gesterone are also major hormones of pregnancy, we believe
that the decrease in PgR occurring during pregnancy is attrib-
utable to the negative effect of progesterone on PgR . Because
estrogen and progesterone also cause differentiation of the
mammary gland, the net effect of these hormones on both
processes leads to the previously observed apparent inverse
relationship between mammary PgR and differentiation (14) .
However, it does not appear that the decrease in PgR and
differentiation are causally related, because during pregnancy
the progression of differentiation as determined by LAD and
a-lactalbumin activity did not result in a progressive loss of
PgR . The second decrease in PgR, which occurs at postpartum,
appears to be specifically related to the secretory state of the
gland rather than to a negative effect of the hormonal milieu
of lactation on PgR .
The mechanisms by which cytoplasmic mammary PgR are
decreased either by hormones or during lactation are not
known . As mentioned earlier, under our present assay condi-
tionswe are measuring total cytoplasmic PgR and thus it is not
likely that the reduction of or lack of PgR is attributable to
endogenously filled sites . But because we only measured cyto-
plasmic PgR, it is conceivable that reduction ofPgR could be
the result of a high concentration of nuclear bound PgR .
However, studies on the nuclear translocation and retention of
PgR in uteri of a number of mammalian species indicate that
a relatively small fraction of total cytoplasmic PgR are ever
translocated to the nucleus (4, 45) . An alternative explanation
for reduced level ofPgR may be the degradation/deactivation
of existing PgR and the failure of new PgR to be synthesized .
In view of a number of reports on the ability of molybdate to
stabilize glucocorticoid and progesterone receptors (26, 30-32)
in various target tissues, we tested its effect on mammary PgR .
We found that 20 mM molybdate added to homogenization
buffer did not enhance PgR binding in virginmammary tissues
and, most importantly, it did not reveal masked or unapparent
PgR in lactating mammary tissue .' However, we cannot rule
out the possibility that PgR are indeed resynthesized but
remain sequestered in the nucleus in a form not bound to
hormone . Although examples of this latter phenomenon are
lacking in normal target tissues, certain human mammary
' S. Z . Haslam andG. Shyamala,unpublished observations .
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unoccupied nuclear receptor sites for estrogen (12, 47). Al-
though further studies are obviously required to determine
what mechanisms are operating to decrease PgR during lacta-
tion in normal mammary tissues, it should be emphasized that
whatever mechanisms are operative they are specific to the
secretory state of the gland.
Thepresent studies have demonstrated for the first time that
progesterone candecrease theconcentration ofits ownreceptor
in mammary tissues, which agrees with similar findings in
uterine tissue (4, 21, 27, 44, 45); this lends further credence to
the concept that progesterone's effects may also be receptor-
mediated in mammarytissue. The present studies also revealed
some important information about the ability of progesterone
to modulate estrogen action in mammary tissue. Progesterone
when administered in combination with estrogen for7 d failed
to affect the estrogen-mediated increase in mammary PgR and,
during this period, the mammary glands were predominantly
ductal and thus undifferentiated. In contrast, when progester-
onewas administered with estrogen to pregnant animalswhose
mammary glands were extensively lobuloalveolar and thus
differentiated, it significantly decreased mammary PgR when
administered with estrogen. Thus, it is tempting to speculate
that the ability of progesterone to decrease PgR may depend
on the state of mammary differentiation and also that this
ability may be acquired during lobuloalveolar differentiation.
This speculation might explain the results of recent studies on
the transplantable urethan-induced mouse mammary carci-
noma MXT-3590, which is of ductal origin. In this tumor,
estrogen can augment both tumorgrowth and PgR concentra-
tion but progesterone fails to antagonize tumor growth (46). It
is possible that the inability of progesterone to antagonize
estrogen-mediated tumor growth is a reflection of the ductal
origin of the MXT-3590 tumor. The effects of estrogen and
progesterone on PgRhave also been examined in dimethylben-
zanthracene-induced primary rat mammary tumors, and from
this study it appears that there can be a dissociation between
estrogenic regulation of mammary growth and PgR(15). How-
ever, that PgR, in both hormone-dependent mouse and rat
mammary tumors, are under acute estrogenic regulation is
most comparable to thesituation presentin mammarytissue of
virgin andpregnant mice, but distinct from theestrogen-insen-
sitive state of lactating mammary tissue.
The effect of estrogen to increase and progesterone to de-
crease PgR has also been reported for uterine tissue (1, 6, 20,
28, 38, 43). However, it is not known whether uterine cytodif-
ferentiation acts to modify the response of the uterus to hor-
mones, as occurs in the mammary gland. In this regard, differ-
ential responsiveness of cells to P or E and P have been
described in oviduct development and function, and such
differences appear to be determined by the typesofcellspresent
and by the stage of oviduct development (32, 33, 35). Also, in
recent studies of estrogen action and estrogen antagonists in
the rat uterus, it has been proposed that the cell type (endo-
metrial vs. myometrial cells) may determine that nature of the
biological response to the hormone antagonists (5).
The mechanisms by which lactation results in mammary
gland estrogen insensitivity, and how this might be reversed,
are currentlybeinginvestigated. Understandinghowcellsmod-
ify their requirement for, or response to, growth regulatory
molecules such as hormones is critical to ourunderstanding of
the basis of the loss ofregulation that occurs in certain disease
states such as neoplasia.
736
￿
THE )OURNAL Or CELL BIOLOGY - VOLUME 86, 1980
The authors thank M. Dowdall, J. Hafiz, and T. Smith for technical
assistance, S. Fraiberg for preparation of the manuscript, and C.
Lalonde and D. Saxe for the illustrations.
These studies were supported by a grant from the National Cancer
Institute of Canada. S. Z. Haslam is a recipient of the National
Institutes of Health National Research Service Award 5F32CA06098-
02 from the National Cancer Institute.
Receivedfor publication 21 December 1980, and in revisedform 18 April
1980.
REFERENCES
I. Brenner, R. M., J. A. Rosko, and N. B. West. 1974. Cyclicchanges in oviductal morphology
and residual cytoplasmic binding capacity induced by sequential estradiol-progesterone
treatment ofspayed Rhesus monkeys. Endocrinology. 95:1094-1104.
2. Bresciani, F. 1965. Effect ofovarian hormones on duration of DNA synthesis of the C3H
mouse. Exp. Cell Res. 38:13-26.
3. Ceriotti, G. 1952. A microchemical determination of desoxyribonucleic acid. J. Biol.
Chem. 198:297-315.
4. Chen. T. 1., and W. W. Leavitl. 1979. Nuclear progesterone receptor in hamster uterus:
Measurement by 'H-progesterone exchange during the estrous cycle. Endocrinology. 104:
1588-1597.
5. Clark, J. H., J. W. Hardin, S. A. McCormack, and H. S. Padykula. 1978. Mechanism of
action of estrogen antagonist: Relationship to estrogen receptor binding and hyperestro-
genization. Prog. Cancer Res. Ther. 10:107-I I5.
6. Clark, J. H., A. J. W. Hsueh, and E. J. Peck, Jr. 1977. Regulation of estrogen receptor
replenishment by progesterone . Ann. N. Y. Acad. Sci. 286:161-179.
7. Cowie, A. T., and J. S. Tindall. 1971. The Physiology ofLactation. H. Davson and A. D.
M. Greenfield, editors. Edward Arnold (Publ) Ltd. London.
8. Davis, J. W., J. Wikman-Cofrelt, and C. L. Eddington. 1972. The effect of progesterone
on biosynthetic pathways in mammary tissue. Endocrinology . 91:1011-1019.
9. Denamur, R., and C. DeLouis. 1972. Effects of progesterone and prolactinon thesecretory
activity and the nucleic acid content of the mammary gland of pregnant rabbits. Acta
Endocrinol. 70:603-617.
10. Ebner, K. E., R. Mawal, D. K. Fitzgerald, and B. Calvin. 1972. a-Lactalbumin and the
synthesis oflactose. Methods Enzymol. 28(Part B):500~510.
11. Freeman, C. S., and Y. J. Topper. 1978. Progesterone is not essential to thedifferentiative
potential ofmammary epithelium in the male mouse. Endocrinology. 103:186-192.
12. Garcia, R., and W. L. McGuire. 1977. An improved assay for nuclear estrogen receptor
in experimental and human breast cancer. Cancer Res. 37:3333-3337.
13. Haslam, S. Z.. and G. Shyamala. 1979. Effect ofoestradiol on progesterone receptors in
normal mammary glands and its relationship to lactation . Biochem. J. 182:127-131.
14. Haslam, S. Z., and G. Shyamala. 1979. Progesterone receptorsin normal mammary glands
of mice: Characterization and relationship to development. Endocrinology. 105:786-795.
15. Horwitz, K. B., and W. L. McGuire. 1977. Progesteron e and progesterone receptors in
experimental breast cancer. Cancer Res. 37:1733-1738.
16. IP, C., and R. L. Dan. 1978. Effect ofestradiol and prolactinongalactosyl-transferase and
rr-laclalbumin activities in rat mammary gland and mammary tumor. Cancer Res. 38:
2077-2081 .
17. Jensen, E. V., and E. R. DeSombre. 1972. Mechanism ofaction of female sex hormones.
Annu. Rev. Biochem. 41 :203-213.
18. Korenman, S. G. 1968. Radio-ligand binding assay of specific estrogens using a soluble
uterine macromolecule. 1. Clin. Endocrinol. Metab. 28:127-130.
19. Kuhn, N. J. 1969. Specificity of progesterone inhibition of lactogenesis. J. Endocrinol. 45:
615-623.
20. Leavitl, W. W., T. J. Chen, and T. C. Allen. 1977. Regulatio n of progesterone receptor
formation by estrogen action. Ann. N. Y. Acad. Sci. 286:210-225.
21. Leung, B. S., and G. H. Sasaki. 1973. Prolactin and progesterone effect on specificestradiol
binding in uterine and mammary tissues in vitro. Biochem. Biophys. Res. Commun. 55:
1180-1184.
22. Lowry,O. H., N.J. Rosebrough, A. L. Farr,and R. J. Randall. 1951. Protein measurements
with Folin phenol reagent. J. Biol. Chem. 193:265-275.
23. Lyons. W. R., C. H. Lt. and R. E. Johnson. 1958. The hormonal control of mammary
growth and lactation. Recent Prog. Horm. Res. 14:219-254.
24. McBlain, W. A., and G. Shyamala. 1979. Inactivation ofmammary cytoplasmic glucocor-
ticoid receptors under cell-free conditions. J. Biol. Chem. 255:3884-3891.
25. McKenzie, L., Fitzgerald. D. K., and Ebner, K. E. 1971 . Lactose synthelase activities in
rat and mouse mammary glands. Biochon. Biophys. Acia. 230:526-531.
26. McGuire, W. L., P. P. Carbone, M. E. Sears, and G. C. Escher. 1975. Estrogen receptors
in human breast cancer. An overview. In Estrogen Receptors in Human Breast Cancer.
W. L. McGuire, P. O. Carbone and E. P. Vollmer, editors. Raven Press, New York. I-9.
27. Mester, T., D. Martel, A. Psychoyos, and E.-E. Baulieu. 1974. Hormonal control of
estrogen receptor in uterus and receptivity for ovo-implantation in the rat. Nature(Loud.).
250:776-778.
28. Milgrom, E. L., T. M. Atger, and E.-E. Baulieu. 1973. Mechanisms regulating the
concentration and conformation of progesterone receptor(s) in the uterus. J. Biol. Chem.
248:6366-6374.
29. Nandi, S. 1958. Endocrine control of mammary gland development and function in the
C3H/He Crgl mouse. J. Nail. Cancer Inst. 21:1039-1048.
30. Neilson. C. G., W. M. Vogel, and W. B. Pratt. 1977. Inactivatio n of glucocorticoid
receptors in cell-free preparations of rat liver. Cancer Res. 37:3420-3426.
31. Nishigon, H., and D. Toß. 1979. Studies on the transformation of avian progesterone
receptor. 61st Annual Meeting of the Endocrine Society, Anaheim, California. 270.
(abstract #791).
32. Oka, T., and R. T. Schimke. 1969. Interaction of estrogen and progesterone in chick
oviduct development. I. Antagonistic effect of progesterone on estrogen-induced prolifer-
ation and differentiation oftubular gland cells. J. Cell Biol. 41:816-831.
33. Oka, T., and R. T. Schinike. 1969. Interaction ofestrogenon progesterone inchick oviduct
development . 11. Effects ofestrogen and progesterone on tubular gland cell function. J.
Cell Biol. 43:123-137.
34. Palmiter, R. D. 1969. Hormone induction and regulation oflactose synthetase in mousemammary gland. Biochem. J 113:409-417.
35. Palmiter, R. D., and l. T. Wrenn. 1971. Interaction ofestrogen and progesterone in chick
oviduct development. 111. Tubular gland cell cytodifferentiation. J. CellBiol. 50:598-615.
36. Philibert . D., and J. P. Raynaud. 1977. Cytoplasmic receptors in mouse uterus. Prog.
Cancer Res. Ther. 4:227-243.
37. Puca, G. A., and F. Bresciani. 1969. Interaction of6,7 'H-I7ß estradiol with mammary
gland and other organs of the C3H mouse in vivo. Endocrinology. 85:1-13.
38. Rao, B. R., and W. G. Wiest. 1973. Progesterone "receptor" in rabbit uterus. 1. Charac-
terization and estradiol-I7ß-augmentation. Endocrinology. 92:1229-1240.
39. Rosen. 1. M., D. L. O'Neal, J. E. McHugh, and J. P. Comstock. 1978. Progesterone-
mediated inhibition ofcasein mRNA and polysomal casein synthesis in the rat mammary
gland during pregnancy. Biochemistry. 17:290-297.
40. Sekhri, K. K., D. R. Pitelka, and K. B. DeOme. 1967. Studies of mouse mammary glands.
11. Cytomorphology of mammary transplants in inguinal fat pads, nipple excised host
glands and whole mammary gland transplants. J. Nail. Cancer Inst. 39:491-503.
41. Shyamala, G., and S. Nandi. 1972. Interactions of 6,7-'H-estradiol in mouse lactating
mammary tissue in vivo and in vitro. Endocrinology . 91 :861-867.
42. Shyamala, G., and W. A. McBlain. 1979. Distinction between progestin- and glucocorti-
coid-binding sites in mammary glands. Biochem. J. 178:345-352.
43. Toft, D. O., and B. W. O'Malley. 1972. Target tissue receptors for progesterone: The
influence ofestrogen treatment. Endocrinology. 90:1041-1045.
44. Vuhai, M. T., F. Logeat, H. Warembourg, and E. Milgrom. 1977. Hormonal control for
progesterone receptors. Ann. N. Y Acad. So. 286:199-209.
45. Walters. M. R., and 1. H. Clark. 1979. Relationshi p between the quantity of progesterone
receptor and the antagonism of estrogen-induced uterotropic response. Endocrinology.
105:382-386.
46. Watson. C. S.. D. Medina,andJ. H.Clark. 1979. Characterization andestrogen stimulation
of cytoplasmic progesterone receptor in the ovarian-dependent MXT-3590 mammary
tumor line. Cancer Res. 39:4098-4104.
47. Zava, D. T., G. C. Chamness, K. B. Horwitz. and W. L. McGuire. 1977. Human breast
cancer: Biologically active estrogen receptor inthe absenceofestrogen? Science (Wash. D.
C). 196:663-664.
HASLAM AND SHVAMALA
￿
Progesterone Receptors and Mammary Differentiation
￿
737